Integration of adeno-associated virus 2 dna in human MKR melanoma cells induces a peptide with oncosuppressive properties

International Journal of Cancer

Volumn 92, Issue 4, 2001, Pages 537-544

  Bantel Schaal, Ursula ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adeno associated virus (AAV); Cytokine induction; Integration; Melanoma cells; Oncosuppression; Terminal differentiation

Indexed keywords

CYTOKINE; TRYPSIN; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL ADHESION; CELL AGING; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; DNA INTEGRATION; ENDOCRINE FUNCTION; FIBROBLAST; HUMAN; HUMAN CELL; MELANOMA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CULTURE MEDIA, CONDITIONED; CYTOKINES; DEPENDOVIRUS; ENDOPEPTIDASE K; HUMANS; MELANOMA; ONCOSTATIN M; PEPTIDES; PHENOTYPE; TRYPSIN; TUMOR CELLS, CULTURED;

EID: 0035874053     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1230     Document Type: Article

References (40)

1. Molecular biology of adeno-associated viruses
2. The roles of AAV Rep proteins in gene expression and targeted integration
3. Biology of adeno-associated virus
4. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter
5. Site-specific integration by adeno-associated virus
6. Targeted integration of adeno-associated virus (AAV) into human chromosome 19
7. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome
8. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome
9. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA
10. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a sitespecific fashion in an immortalized epithelial cell line
11. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells
12. Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein
13. Parvoviridae: The viruses and their replication
14. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
15. AAV vectors: Is clinical success on the horizon?
16. Parvoviral vectors for the gene therapy of cancer
17. Autonomous parvoviruses
18. Growth properties of a human melanoma cell line are altered by adeno-associated parvovirus type 2
19. Chromosomal integration of adeno-associated parvovirus DNA limits proliferation and dispersal of human MKr melanoma cells in co-cultures with human fibroblasts
20. Adeno-associated virus and development of cervical neoplasia
21. Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17
22. Adeno-associated parvoviruses inhibit growth of cells derived from malignant human tumors
23. Influence of adeno-associated virus on adherence and growth properties of normal cells
24. Encapsidation of adeno-associated virus type 2 rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells
25. Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosporylated pRb
26. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
27. Senescence of nickeltransformed cells by an X chromosome: Possible epigenetic control
28. A role for the MEK/ MAPK pathway in PMA-induced cell cycle arrest: Modulation of megakaryocytic differentiation of K562 cells
29. Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta
30. Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell-cycle-regulation proteins
31. Perturbation of the cell cycle by adeno-associated virus
32. TGF-beta and fibrosis
33. TGF-beta and cancer
34. Tumor necrosis factor-alpha: Molecular-biological aspects minireview
35. Oncostatin M: A growth regulator produced by dasifferentiated histiocytic lymphoma cells
36. Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease
37. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form
38. Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M
39. The recombination signals for adeno-associated virus site-specific integration
40. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules